abstract |
The present invention relates to compounds containing a liver-specific viral vector and having anti-inflammatory activity, said compounds comprising: - a nucleic acid of interest represented by the sequence SEQ ID NO: 2, and encoding a polypeptide of interest shown by the sequence SEQ ID NO: 1, or - a nucleic acid of interest represented by a sequence having at least 83%, particularly 90%, in particular 95% identity with the sequence SEQ ID NO: 2; or a polypeptide of interest represented by the sequence SEQ ID NO: 1, or a polypeptide of interest represented by a sequence having at least 83%, particularly 90%, in particular 95% identity with the sequence SEQ ID NO: 1, for the preparation of a medicament for the treatment of pathologies associated with an inflammatory condition |